Americas Gold Nanoparticles Market is Growing at a Healthy CAGR During Forecast to 2027
Americas
Gold Nanoparticles Market - Overview
Nano
therapy is a modern technique for treatment of various diseases and performed
with the help of submicron sized molecular devices or nanoparticles. According
to the National Cancer Institute (2014), over 16 lakh Americans had cancer,
which is expected to increase during the given period. Increasing prevalence of
diseases such as diabetes and cancer, rising demand for the better treatment
options, and increasing healthcare expenditure drives the growth of the market.
According to the International Diabetes Federation, about 420 million adult
population in the world was suffering from diabetes in 2016, which is
increasing at the rate of 8.4% per year and is expected to reach 625 million by
2040.
Furthermore,
the government support for research and continuous improvement in healthcare
infrastructure boost the market growth. However, higher cost of the treatment
and strict regulatory norms may slow the growth of the Americas gold
nanoparticles market over the forecast period.
According
to a recent study report published by the Market Research Future, the Americas Gold Nanoparticles Market Trends is
booming, and expected to gain prominence over the forecast period growing
rapidly .The market is expected to demonstrate a spectacular growth by 2027,
surpassing its previous growth records in terms of value with a striking CAGR
during the anticipated period (2017 – 2027).
Americas Gold Nanoparticles Market - Competitive
Analysis:
Cytodiagnostics (U.S.), NanoHybrids Corp (U.S.),
BBI Solutions (U.S.), NanoSphere, Inc. (U.S.), Smith and Nephew (U.K), Selecta
Biosciences, Inc. (U.S.), Sirnaomics, Inc. (U.S.), Tarveda Therapeutics (U.S.),
Nanobiotix (France), Nanoprobes, Inc. (U.S.), Nanosphere Inc. (U.S.), NanoMedia
Solutions Inc. (Japan), NanoBio Corporation (U.S.), NanoBioMagnetics (U.S.) are some of the prominent players at
Americas
Gold Nanoparticles Market - Regional Analysis
North
America dominates the Americas gold nanoparticles market owing to increasing
prevalence of cancer and other chronic diseases, well-developed healthcare
sector, and growing demand for the better treatment. North America is segmented
into two regions: the U.S. and Canada. The U.S. accounts for the major share in
the market owing to the high healthcare spending and increasing government
support for research & development. South America is the fastest growing
market due to the presence of huge opportunities for the development of the
market. According to the American Diabetic Association (2012), 29 million
Americans had diabetes, which was 9.3% of the total American population and as
per the National Cancer Institute (2016), about 1,685,210 new cases of cancer
had been diagnosed in the U.S. In Canada, the market for gold nanoparticles
shows significant growth owing to the rising awareness about the nanotechnology
and extensive research in the field of nanotechnology. In South America, the
market exhibits steady but positive growth owing to an increasing emphasis on
preventive care and growth of healthcare industry. On the other hand, the
higher cost of treatment and lack of awareness about treatment may hinder the
growth of the Americas gold nanoparticles market.
Related Reports:
Urethral Stricture Market Research
Report Forecast to 2023
Contact Lenses Market Research Report - Global
Forecast till 2025
Hair Transplant Market Insights
2019-2023
Comments
Post a Comment